---
figid: PMC4129373__fimmu-05-00386-g001
figtitle: Schematic cartoon of TLR signaling pathways
organisms:
- Escherichia coli
- Staphylococcus aureus
- Mycobacterium tuberculosis
- Pseudomonas aeruginosa
- Helicobacter pylori
- Listeria monocytogenes
- Streptococcus pneumoniae
- Mycobacterium tuberculosis variant bovis BCG
- Porphyromonas gingivalis
- Haemophilus influenzae
- Mycobacterium tuberculosis variant bovis
- Fusobacterium nucleatum
- Borreliella burgdorferi
- Neisseria gonorrhoeae
- Salmonella enterica subsp. enterica serovar Typhi
- Clostridium butyricum
- Chlamydia muridarum
- Shigella dysenteriae
- Neisseria lactamica
- Mus musculus
- Rattus norvegicus
- Candida dubliniensis
- Aspergillus fumigatus
- Homo sapiens
- Respiratory syncytial virus
- Triportheus paranensis
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC4129373
filename: fimmu-05-00386-g001.jpg
figlink: /pmc/articles/PMC4129373/figure/F1/
number: F1
caption: Schematic cartoon of TLR signaling pathways. TLR2/TLR1 and TLR2/TLR6 heterodimers
  and TLR4 and TLR5 homodimers are located on the cell surface, while TLR3, TLR7,
  TLR8 and TLR9 homodimers have an intracellular localization. Occasionally, in specific
  epithelial cell types and tissues, TLR4 can be expressed intracellularly or TLR3
  and TLR9 on the cell surface. Ligand binding to the leucine-rich repeat (LRR) domain
  of TLR dimers brings the TIR domains of adjacent TLRs in proximity, allowing multiple
  signaling pathways via different adaptor molecules. TLR2/TLR1 and TLR3 potentially
  cooperate with CD14, TLR2/TLR6 with CD36 and TLR4 requires LBP, CD14 and MD-2. TLR1,
  TLR2, TLR4, TLR5, TLR6, TLR7, TLR8 and TLR9 activate the MyD88-dependent pathway,
  with cooperation of Mal for TLR2 and TLR4. Through MyD88, IRAKs and TRAF6, TLR2/TLR1
  and TLR2/TLR6, TLR4, TLR5, TLR7, TLR8, and TLR9 signaling pathways lead to activation
  of NF-κB and MAPKs, with production of inflammatory cytokines and chemokines, type-II
  interferon, mucins, and defensins (solid thick arrows). TLR7, TLR8, and TLR9 also
  induce MyD88-dependent activation of TRAF6 and TRAF3 (dashed arrows). TLR3 and TLR4
  activate a MyD88-independent pathway via TRIF and, in cooperation with TRAM for
  TLR4 (solid medium arrows), also leading to NF-κB and MAPKs activation and of inflammatory
  mediators, type-II interferon, mucins, and defensins.The MyD88-independent pathway
  also induces IRF3 and IRF7 activation, with production of type-I IFNs and IL-10
  gene activation.
papertitle: TLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial Pathogens.
reftext: Ryan McClure, et al. Front Immunol. 2014;5:386.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.948867
figid_alias: PMC4129373__F1
figtype: Figure
redirect_from: /figures/PMC4129373__F1
ndex: c2e14442-def8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4129373__fimmu-05-00386-g001.html
  '@type': Dataset
  description: Schematic cartoon of TLR signaling pathways. TLR2/TLR1 and TLR2/TLR6
    heterodimers and TLR4 and TLR5 homodimers are located on the cell surface, while
    TLR3, TLR7, TLR8 and TLR9 homodimers have an intracellular localization. Occasionally,
    in specific epithelial cell types and tissues, TLR4 can be expressed intracellularly
    or TLR3 and TLR9 on the cell surface. Ligand binding to the leucine-rich repeat
    (LRR) domain of TLR dimers brings the TIR domains of adjacent TLRs in proximity,
    allowing multiple signaling pathways via different adaptor molecules. TLR2/TLR1
    and TLR3 potentially cooperate with CD14, TLR2/TLR6 with CD36 and TLR4 requires
    LBP, CD14 and MD-2. TLR1, TLR2, TLR4, TLR5, TLR6, TLR7, TLR8 and TLR9 activate
    the MyD88-dependent pathway, with cooperation of Mal for TLR2 and TLR4. Through
    MyD88, IRAKs and TRAF6, TLR2/TLR1 and TLR2/TLR6, TLR4, TLR5, TLR7, TLR8, and TLR9
    signaling pathways lead to activation of NF-κB and MAPKs, with production of inflammatory
    cytokines and chemokines, type-II interferon, mucins, and defensins (solid thick
    arrows). TLR7, TLR8, and TLR9 also induce MyD88-dependent activation of TRAF6
    and TRAF3 (dashed arrows). TLR3 and TLR4 activate a MyD88-independent pathway
    via TRIF and, in cooperation with TRAM for TLR4 (solid medium arrows), also leading
    to NF-κB and MAPKs activation and of inflammatory mediators, type-II interferon,
    mucins, and defensins.The MyD88-independent pathway also induces IRF3 and IRF7
    activation, with production of type-I IFNs and IL-10 gene activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tlr1
  - Tlr2
  - Tlr6
  - Tlr4
  - Tlr5
  - Tlr10
  - Lbp
  - Ehhadh
  - Ly96
  - Mal
  - Pnma1
  - Myd88
  - Cd14
  - Tlr3
  - Rnf138
  - Irf5
  - Tlr7
  - Tlr8
  - Traf6
  - Traf3
  - Ralbp1
  - Tlr9
  - Map3k7
  - Tbk1
  - Nfkb1
  - Irf3
  - Irf7
  - Il10
  - Slc13a2
  - Cd36
  - TLR1
  - TLR2
  - TLR6
  - TLR4
  - TLR5
  - TLR10
  - LBP
  - EHHADH
  - RPSA
  - LY96
  - MAL
  - MRTFA
  - TIRAP
  - PNMA1
  - GSTZ1
  - MYD88
  - CD14
  - NDUFA2
  - TRAM1
  - TICAM2
  - TMED7-TICAM2
  - TLR3
  - TRIM69
  - TICAM1
  - IRF5
  - TLR7
  - TLR8
  - TRAF6
  - TRAF3
  - RIPK1
  - KRR1
  - TLR9
  - MAP3K7
  - NR2C2
  - IKBKE
  - TBK1
  - NFKB1
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - IRF3
  - IRF7
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - IL10
  - IFNA1
  - MUC5AC
  - CD36
  - Tirap
  - Mrtfa
  - Tmed7
  - Ticam2
  - Trim69
  - Ticam1
  - Ripk1
  - Nr2c2
  - Ikbke
  - Jun
  - Scarb1
  - tlr1
  - tlr2
  - tlr5b
  - tirap
  - malb
  - myd88
  - tram1
  - tlr3
  - ticam1
  - irf5
  - tlr7
  - traf6
  - traf3
  - ripk1l
  - tlr9
  - tbk1
  - irf3
  - irf7
  - il10
  - ifnphi1
  - carmil1
  - cd36
---
